Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find the best way to prevent heart disease and stroke in
people with lupus (systemic lupus erythematosis, or SLE). The study will evaluate the
effectiveness of medication and a phone-based education program in controlling four risk
factors for heart disease: smoking, obesity, high blood pressure, and inactivity. The study
will also test the safety of commonly used heart medications in people with lupus.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)